AU2021466375A1 - Drug for treating fatty liver and non-alcoholic steatohepatitis - Google Patents
Drug for treating fatty liver and non-alcoholic steatohepatitis Download PDFInfo
- Publication number
- AU2021466375A1 AU2021466375A1 AU2021466375A AU2021466375A AU2021466375A1 AU 2021466375 A1 AU2021466375 A1 AU 2021466375A1 AU 2021466375 A AU2021466375 A AU 2021466375A AU 2021466375 A AU2021466375 A AU 2021466375A AU 2021466375 A1 AU2021466375 A1 AU 2021466375A1
- Authority
- AU
- Australia
- Prior art keywords
- amino acid
- fatty liver
- peptide
- acid sequence
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2021/036238 WO2023053384A1 (ja) | 2021-09-30 | 2021-09-30 | 脂肪肝および非アルコール性脂肪肝炎の治療薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2021466375A1 true AU2021466375A1 (en) | 2024-04-11 |
Family
ID=85781770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021466375A Pending AU2021466375A1 (en) | 2021-09-30 | 2021-09-30 | Drug for treating fatty liver and non-alcoholic steatohepatitis |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240299496A1 (https=) |
| EP (1) | EP4410302A4 (https=) |
| JP (1) | JP7798300B2 (https=) |
| KR (1) | KR20240070640A (https=) |
| CN (1) | CN118317780A (https=) |
| AU (1) | AU2021466375A1 (https=) |
| CA (1) | CA3233234A1 (https=) |
| MX (1) | MX2024003974A (https=) |
| WO (2) | WO2023053384A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3358011T (pt) | 2011-04-26 | 2020-04-23 | Univ Osaka | Péptido para induzir a regeneração de um tecido e a sua utilização |
| US20200038486A1 (en) | 2017-04-07 | 2020-02-06 | StemRIM Inc. | Therapeutic medicine for fibrous disease |
| EP3728593A1 (en) * | 2017-12-18 | 2020-10-28 | Alnylam Pharmaceuticals, Inc. | High mobility group box-1 (hmgb1) irna compositions and methods of use thereof |
| US11684653B2 (en) * | 2019-03-06 | 2023-06-27 | The Cleveland Clinic Foundation | Compositions and method for reducing virulence of microorganisms |
-
2021
- 2021-09-30 AU AU2021466375A patent/AU2021466375A1/en active Pending
- 2021-09-30 CA CA3233234A patent/CA3233234A1/en active Pending
- 2021-09-30 WO PCT/JP2021/036238 patent/WO2023053384A1/ja not_active Ceased
- 2021-09-30 KR KR1020247014019A patent/KR20240070640A/ko active Pending
- 2021-09-30 JP JP2023550943A patent/JP7798300B2/ja active Active
-
2022
- 2022-09-30 MX MX2024003974A patent/MX2024003974A/es unknown
- 2022-09-30 EP EP22876529.3A patent/EP4410302A4/en active Pending
- 2022-09-30 WO PCT/JP2022/036662 patent/WO2023054666A1/ja not_active Ceased
- 2022-09-30 CN CN202280078804.6A patent/CN118317780A/zh active Pending
- 2022-09-30 US US18/697,330 patent/US20240299496A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240299496A1 (en) | 2024-09-12 |
| EP4410302A1 (en) | 2024-08-07 |
| EP4410302A4 (en) | 2025-07-23 |
| KR20240070640A (ko) | 2024-05-21 |
| CA3233234A1 (en) | 2023-04-06 |
| WO2023054666A1 (ja) | 2023-04-06 |
| CN118317780A (zh) | 2024-07-09 |
| JPWO2023053384A1 (https=) | 2023-04-06 |
| WO2023053384A1 (ja) | 2023-04-06 |
| MX2024003974A (es) | 2024-07-09 |
| JP7798300B2 (ja) | 2026-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11298403B2 (en) | Therapeutic agent for inflammatory bowel disease | |
| KR102607543B1 (ko) | 담즙산 항상성의 조절 및 담즙산 질환 및 질병의 치료 방법 | |
| US20220380420A1 (en) | Therapeutic Agent for Psoriasis | |
| EA011583B1 (ru) | Миметические антитела glp-1 человека, композиции, способы и применения | |
| JP2023030070A (ja) | 線維性疾患の治療薬 | |
| US11446376B2 (en) | Methods for treating heart failure using glucagon receptor antagonistic antibodies | |
| EP4375380A1 (en) | Drug for preventing, alleviating or treating mucosal adhesion and use thereof | |
| ZA200603396B (en) | Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions | |
| US20130072441A1 (en) | Protease Inhibitors and Preventives or Remedies for Disease | |
| WO2023217267A1 (zh) | 包含utr的核酸构建体及其应用 | |
| JP2001506586A (ja) | ケラチノサイト増殖因子―２の使用 | |
| AU2021466375A1 (en) | Drug for treating fatty liver and non-alcoholic steatohepatitis | |
| US20070154534A1 (en) | Use of secretin in the treatment of schizophrenia | |
| KR20200108494A (ko) | 근위축성 측삭 경화증 치료제 | |
| CN108434439B (zh) | 钙网蛋白的医药用途 | |
| KR102445482B1 (ko) | 오가노이드 및 항염증제를 포함하는 염증성 장질환의 예방 또는 치료용 약학 조성물 | |
| CN112423772A (zh) | Rps2肽调节内皮细胞功能障碍的用途 | |
| HK40107111A (en) | Drug for treating fatty liver and non-alcoholic steatohepatitis | |
| JP7838772B2 (ja) | Ｆｇｆ５の転写体変異体－２及びそのタンパク質の肝線維症の予防、抑制、及び治療用途 | |
| EP1608396B1 (en) | Use of soluble cd14 for treatment of diseases | |
| TW200410709A (en) | Asialo-interferons and the treatment of liver cancer | |
| JP2007137771A (ja) | 炎症性疾患治療剤、およびその利用 | |
| WO2005087925A1 (ja) | 組換遺伝子，疾患動物モデル，及び被験物の評価方法 | |
| WO2006016450A1 (ja) | 脳梗塞の予防・治療方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ DRUG FOR TREATING FATTY LIVER AND NON-ALCOHOLIC STEATOHEPATITIS |